医学
淋巴结
神经内分泌肿瘤
普通外科
神经内分泌肿瘤
放射科
结果(博弈论)
胰腺
胰腺神经内分泌肿瘤
胰腺切除术
胰腺疾病
外科
外科切除术
肿瘤科
内科学
切除术
胰十二指肠切除术
奥曲肽
胰腺肿瘤
淋巴
作者
Fabiola A. Bechtiger,Anna Nießen,Ulf Hinz,Magdalena Lewosinska,Alexander Hamm,Zoltán Czigány,Franck Georges Billmann,Thilo Hackert,Markus Wolfgang Büchler,Simon J. Schimmack
出处
期刊:Surgery
[Elsevier BV]
日期:2025-09-25
卷期号:188: 109730-109730
被引量:1
标识
DOI:10.1016/j.surg.2025.109730
摘要
OBJECTIVE: Optimal treatment strategies for small (≤2 cm) nonfunctioning pancreatic neuroendocrine neoplasms are still subject to discussion. The aim of this study was to analyze real-world data of patients with pancreatic neuroendocrine neoplasms ≤2 cm regarding the indications for surgery and long-term postresection survival. METHODS: All patients undergoing surgery for nonfunctioning pancreatic neuroendocrine neoplasms ≤2 cm between 2003 and 2023 were analyzed. Indications for surgery, clinicopathologic parameters, and long-term survival were assessed. Differences between pancreatic neuroendocrine neoplasms <1 cm and 1-2 cm were evaluated. RESULTS: Of a total of 806 resected pancreatic neuroendocrine neoplasms, 237 patients had a lesion ≤2 cm (29.4%), 85 of which were smaller than 1 cm. The 3 most common indications for surgery for pancreatic neuroendocrine neoplasms ≤2 cm were either suspicion of a non-neuroendocrine neoplasm malignancy (55.2%), suspicion of neuroendocrine tumor (25.9%), or obstruction of the pancreatic duct (9.4%). Tumor differentiation was 84% G1, 15% G2, and 1.3% G3. Noticeably, 5.1% of pancreatic neuroendocrine neoplasms ≤2 cm had lymph node metastasis (pN1). Five patients with a small pancreatic neuroendocrine neoplasm developed distant metastasis (pM1). The 10-year overall survival was 86.9% for <1 cm and 84.5% for 1-2 cm (P = .964). 10-year disease-free survival was 83.1% in patients with a pancreatic neuroendocrine neoplasms <1 cm and 81.1% for pancreatic neuroendocrine neoplasms 1-2 cm (P = .784). CONCLUSION: Surgical treatment of small (≤2 cm) pancreatic neuroendocrine neoplasms provides excellent long-term survival. Since even small pancreatic neuroendocrine neoplasms can develop lymph node and distant metastases, treatment decisions should not be determined on the basis of tumor size alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI